Summary
Background Large-scale school closures have been implemented worldwide to curb the spread of COVID-19. However, the impact of school closures and re-opening on epidemic dynamics remains unclear.
Methods We simulated COVID-19 transmission dynamics using an individual-based stochastic model, incorporating social-contact data of school-aged children during shelter-in-place orders derived from Bay Area (California) household surveys. We simulated transmission under observed conditions and counterfactual intervention scenarios between March 17-June 1, and evaluated various fall 2020 K-12 reopening strategies.
Findings Between March 17-June 1, assuming children <10 were half as susceptible to infection as older children and adults, we estimated school closures averted a similar number of infections (13,842 cases; 95% CI: 6,290, 23,040) as workplace closures (15,813; 95% CI: 9,963, 22,617) and social distancing measures (7,030; 95% CI: 3,118, 11,676). School closure effects were driven by high school and middle school closures. Under assumptions of moderate community transmission, we estimate that fall 2020 school reopenings will increase symptomatic illness among high school teachers (an additional 40.7% expected to experience symptomatic infection, 95% CI: 1.9, 61.1), middle school teachers (37.2%, 95% CI: 4.6, 58.1), and elementary school teachers (4.1%, 95% CI: −1.7, 12.0). Results are highly dependent on uncertain parameters, notably the relative susceptibility and infectiousness of children, and extent of community transmission amid re-opening. The school-based interventions needed to reduce the risk to fewer than an additional 1% of teachers infected varies by grade level. A hybrid-learning approach with halved class sizes of 10 students may be needed in high schools, while maintaining small cohorts of 20 students may be needed for elementary schools.
Interpretation Multiple in-school intervention strategies and community transmission reductions, beyond the extent achieved to date, will be necessary to avoid undue excess risk associated with school reopening. Policymakers must urgently enact policies that curb community transmission and implement within-school control measures to simultaneously address the tandem health crises posed by COVID-19 and adverse child health and development consequences of long-term school closures.
Funding JVR, JRH, QC, PAC, SP, AKH, CMH, and KC were supported in part by National Science Foundation grant no. 2032210, National Institutes of Health grants nos. R01AI125842, R01TW010286 and R01AI148336, and by the University of California Multicampus Research Programs and Initiatives award # 17-446315. JAL received support from the Berkeley Population Center (grant number P2CHD073964 from the National Institute of Child Health & Human Development, National Institutes of Health).
Evidence before this study Given the urgent need to enact quick public health interventions to curb transmission of SARS-CoV-2, large-scale school closures were implemented globally. We searched the terms “school”, “children”, “closure”, “coronavirus”, and “COVID-19” in PubMed to assess the current evidence evaluating the role of school closures in mitigating SARS-CoV-2 transmission. Data motivating the decision to close schools remained largely limited to experiences with influenza outbreaks, where children are highly susceptible to infection, are key drivers of transmission, and experience severe outcomes. At the time of writing, no modeling studies to our knowledge have quantified the net impact of COVID-19 related school closures in the United States, and observational studies that documented decreases in COVID-19 incidence associated with statewide school closures are subject to confounding by other concurrently implemented non-pharmaceutical interventions. Further, the scientific consensus remains fragmented in its understanding of key epidemiological parameters, namely the relative susceptibility and infectiousness of children compared to adults, exacerbating uncertainties around the risks of opening schools. As policymakers weigh the negative consequences of school closures on child health and development against the risks of reopening, it becomes critical to discern the range of potential impacts of school reopenings on the COVID-19 epidemic accounting for uncertainty in epidemiological parameters and plausible strategies for risk mitigation.
Added value of this study This study uses an individual-based transmission model parameterized with contact patterns we derived from a web-based contact survey administered to Bay Area (California) households with children during school closures to advance the understanding of the relative impact of Bay Area spring 2020 school closures compared to other non-pharmaceutical interventions, and projects the potential impact of school reopening strategies in the fall 2020 semester. Within the context of our model, we found that school closures averted a similar number of cases as workplace closures in spring 2020, with most of the averted cases attributable to high school closures. We found that COVID-19 risks associated with reopening schools in fall 2020 are highly dependent on the relative susceptibility of children and the level of community transmission at the time of reopening. Strategies necessary to reduce school transmission such that fewer than an additional 1% of teachers would be infected varied across school divisions. Safely reopening high schools may require combining multiple strict contact reduction measures, including staggering school days, halving class sizes, or maintaining small, stable cohorts, while safely reopening elementary schools may be achieved with a more limited set of interventions, including use of stable cohorts and masks.
Implications of all the available evidence Under plausible assumptions regarding the susceptibility and infectiousness of school-aged children and teenagers, this study highlights heterogeneity of COVID-19 risks, and necessary mitigation strategies, associated with reopening across levels of schooling. It also highlights the urgency of resolving uncertain parameters, especially those pertaining to the relative susceptibility and infectiousness of children. Research is needed to quantify the role of children in transmission of COVID-19 in schools or similar settings to enumerate the risk of school-based outbreaks, particularly as transmission remains high in many regions of the United States. To balance both the adverse long-term consequence of school closures on child development and concerns about safe reopening, policy makers must quickly devote resources to ensure schools that choose to reopen amid uncertain evidence can adopt and adhere to strict infection, prevention, and control strategies that are critical to ensuring students, teachers, and community members remain healthy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
JVR, JRH, QC, PAC, SP, AKH, CMH, and KC were supported in part by National Science Foundation grant no. 2032210, National Institutes of Health grants nos. R01AI125842, R01TW010286 and R01AI148336, and by the University of California Multicampus Research Programs and Initiatives award # 17-446315. JAL received support from the Berkeley Population Center (grant number P2CHD073964 from the National Institute of Child Health & Human Development, National Institutes of Health).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Institutional Review Board at the University of California, Berkeley (Protocol Number: 2020-04-13180). Prior to taking the anonymous survey, parents were provided a description of the survey and were asked to provide written informed consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
COVID-19 data used in models are publicly available. Social contact data is available by request in aggregate form.
